Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Semler Scientific To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Semler Scientific between March 10, 2021 and April 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. ...

NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2025. SO WHAT: If you purchased Jasper Therapeutics secu ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in KBR between May 6, 2025 and June 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) - ...

https://securitiesclasslaw.com/securities/savara-inc-loss-submission-form/?id=168877&from=4 CLASS PERIOD: March 4, 2024 to May 23, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) MOLBREEVI BLA, the treatment of pulmonary alveolar proteinosis, lacked sufficient information regarding MOLBREEVI's chemistry, manufacturing, and/or controls; (ii) accordingly, FDA was unlikely to approve the MO ...

Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In SelectQuote To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in SelectQuote between September 9, 2020 and May 1, 2025and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330Â (Ext. 1310). [You may also click here for additional i ...

公司潜在违规行为 - 公司被指控在加州海岸未实际重启石油生产的情况下做出虚假和/或误导性陈述 [4] - 公司高管因违反联邦证券法被提起诉讼 相关陈述缺乏合理依据 [4] 股价波动事件 - 2025年5月28日公司股价单日下跌5.04美元 跌幅达15.3% 收盘报27.89美元 [5] - 股价下跌直接原因是加州海岸委员会获得法院初步禁令 阻止公司在圣巴巴拉县沿海区域的管道维修活动 [5] 法律程序进展 - 联邦证券集体诉讼的牵头原告申请截止日期为2025年9月26日 [2] - 律师事务所正在征集损失超过5万美元的投资者参与诉讼 涉及2025年5月19日至6月3日期间交易和/或5月21日二次公开发行(SPO)的投资者 [1] 公司背景信息 - 公司股票在纽约证券交易所上市 交易代码为SOC [2] - 公司业务涉及加州海岸的石油生产及管道维修维护活动 [5]

NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who purchased or otherwise acquired Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) securities between November 30, 2023 and July 3, 2025, inclusive (the “Class Period”). The Complaint alleges that Defendants made false and/or misleading state ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Semler Scientific To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Semler Scientific between March 10, 2021 and April 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept ...

公司财务问题 - 公司在截至2025年3月31日的财年存在不当确认收入行为[6] - 公司需重述截至2024年12月31日的第三季度财务报表[6] - 重述将显示收入减少约390万美元[9] 股价影响 - 2025年6月30日股价下跌1美元（10.03%）至8.97美元[7] - 2025年8月11日股价下跌0.14美元（1.79%）至7.66美元[9] - 2025年8月19日股价下跌0.61美元（8.2%）至6.83美元[10] 公司治理变动 - 首席执行官在任职五个月后于2025年8月18日宣布辞职[9] - 公司披露财务报告内部控制存在重大缺陷[9] - 公司披露控制程序存在重大缺陷[9] 法律程序 - 联邦证券集体诉讼的牵头原告申请截止日期为2025年11月3日[4] - 诉讼指控公司做出虚假和误导性陈述[6] - 律师事务所正在调查潜在索赔并征集损失超过7.5万美元的投资者[1]